Die Gesamtkosten für die Behandlung eines Desmoidtumors in der Türkei hängen von den spezifischen diagnostischen und therapeutischen Verfahren ab. Erstkonsultationen mit einem Spezialisten kosten 104 €, während eine Biopsie und histochemische Analyse 113 € pro Block kosten. Bildgebende Verfahren wie ein Thorax-CT und ein abdominaler Ultraschall kosten jeweils 311 € und 217 €. Umfassende Bluttests, einschließlich Hepatitis-Marker, belaufen sich auf 906 €. Der gesamte Behandlungsplan wird nach Erhalt der Testergebnisse und einer ärztlichen Bewertung abgeschlossen.
17 Jahre Spezialisierung auf Onkologie – Dr. Solak wurde am Krebsinstitut der Hacettepe-Universität und am MD Anderson Cancer Center ausgebildet.
Dr. Banu Atalar ist Fachärztin für Strahlentherapie (Türkei, 2004). Sie ist seit 2018 Professorin an der Acibadem MAA University und seit 2026 klinisch am Anadolu Medical Center tätig. Ihre Ausbildung absolvierte sie an den Universitäten Istanbul und Cerrahpaşa. 2011 schloss sie ein klinisches Forschungsstipendium an der Stanford University in stereotaktischer Radiochirurgie ab. Ihr Schwerpunkt liegt auf Tumoren des ZNS, des Thorax und des Gastrointestinaltrakts. Rund 75 % ihrer Behandlungen entfallen auf SRS (stereotaktische Radiochirurgie) und MR‑geführte adaptive SRS.
Zu ihren Auszeichnungen zählen der ASCO IDEA Award (2004), der IASLC International Mentorship Award (2018) und H.FACR (2025). Sie hat 72 internationale, peer‑reviewte Publikationen. Zu ihren Leitungsfunktionen zählen die Präsidentschaft der Türkischen Gesellschaft für Radioonkologie (2025–27) und der Vorsitz des ESTRO National Societies Committee (2024–27). Sie war Mitglied des ASCO Resource‑Stratified Guidelines Committee (2013–18) sowie der RSS‑Tagungs- und Nominierungsausschüsse. Sie organisierte nationale Kongresse (2023, 2025) und war als eingeladene Referentin auf großen Fachkongressen vertreten.
Prof. Hüseyin Baloğlu ist Facharzt für Pathologie am Anadolu Medical Center in Gebze, Kocaeli, Türkei. Seine Schwerpunkte sind Molekularpathologie, chirurgische Pathologie sowie Tumorbiopsie und -diagnostik.
Ausbildung und Qualifikationen: MD, GATA Medical School (1986). Facharztausbildung in Pathologie, GATA (1992). Außerordentlicher Professor (Doçent), GATA (2004). Gastwissenschaftler am Albert Einstein College of Medicine (New York) und an der Universität Heidelberg.
Leistungen: Autor von über 600 peer‑reviewten Publikationen. Inhaber eines Patents in der molekularen Diagnostik von Schilddrüsenkrebs. Leitet die Bereiche Liquid Biopsy und Präzisionsonkologie.
Prof. Sezer Sağlam ist Professor für medizinische Onkologie mit umfassender Erfahrung in der gastrointestinalen Onkologie am Gayrettepe Florence Nightingale Krankenhaus.
Surgery is no longer the primary treatment for desmoid tumors in Turkey. Many oncology centers now recommend active surveillance as the first-line approach. Medical specialists prioritize non-invasive therapies like hormonal treatment or tyrosine kinase inhibitors to manage these tumors while minimizing the risk of recurrence.
Bookimed Expert Insight: Turkish oncology centers often implement findings from international research to reduce surgical intervention. Dr. Nail Paksoy at Medipol Bahçelievler has published research on the effectiveness of sorafenib for progressive desmoid tumors. This shift toward targeted drug therapy helps patients avoid complex surgeries while effectively controlling tumor growth.
Patient Consensus: Patients note it is important to find specialized sarcoma teams because surgery often carries a high risk of the tumor returning. Many find success managing the condition through long-term monitoring rather than rushing into an operation.
Desmoid tumors do not metastasize or spread to distant organs via the bloodstream or lymphatic system. These tumors are locally aggressive and invade surrounding muscle and nerves. While they are not malignant, they often recur in the same area after surgical removal.
Bookimed Expert Insight: Turkish oncology centers provide access to dual-specialized expertise often missing elsewhere. Dr. Nail Paksoy at Medipol Bahçelievler has specialized research in sorafenib for progressive cases. This focus on medical oncology rather than just surgery is vital because surgery frequently triggers further tumor growth.
Patient Consensus: Patients note that finding a dedicated sarcoma specialist is essential because these tumors behave uniquely. Many emphasize that watchful waiting is often safer than immediate surgery to avoid recurrence.
Treatment for a desmoid tumor in Turkey usually requires 7 to 14 days for surgery or initial evaluations. If your plan includes radiation therapy, your stay may extend to several weeks for daily sessions. Complex surgical cases require extra time for recovery and pathology results before travel.
Bookimed Expert Insight: Patient volume data highlights Turkey as a leading hub, with Medipol Mega University Hospital serving 1,000,000 patients annually. High-capacity centers like this often provide faster pathology results than smaller clinics. This efficiency can reduce your stay by 2 or 3 days during the critical diagnostic phase.
Patient Consensus: Patients note it is important to pack extra clothes and funds for unexpected buffer days. They suggest confirming if the schedule includes time for final imaging before booking return flights.
Turkey hosts specialist oncologists and multidisciplinary sarcoma teams managing rare desmoid tumors. Notable experts include Dr. Nail Paksoy at Medipol Bahçelievler University Hospital. He holds ESMO Board Certification. Leading JCI-accredited centers like Anadolu Medical Center and Istanbul Florence Nightingale provide specialized care.
Bookimed Expert Insight: Turkish oncology leads often specialize in specific medical sub-groups rather than just general cancer. Dr. Nail Paksoy at Medipol leads international clinical trials specifically focusing on desmoid tumor outcomes. This academic focus ensures patients receive protocols validated by global research standards.
Patient Consensus: Patients emphasize finding a doctor who prioritizes non-surgical observation over immediate resection. They recommend confirming pathology results with a multidisciplinary tumor board before starting treatment.
Yes, you must bring original pathology slides and imaging (CDs or USB drives) to Turkey. Desmoid tumors are rare and complex. Turkish specialists require these materials to verify your diagnosis. Having originals prevents repeat tests and saves time during your treatment planning.
Bookimed Expert Insight: Desmoid tumors require highly niche expertise often found at Anadolu Medical Center, which is affiliated with Johns Hopkins Hospital. Our data shows that top specialists like Assoc. Prof. Nail Paksoy at Medipol have published specific research on desmoid treatments. Bringing your original slides allows these experts to apply their specialized knowledge immediately, rather than waiting weeks for international transfers.
Patient Consensus: Patients emphasize that carrying original slides is vital because specialists value physical tissue over written reports when confirming rare cases. They suggest keeping everything in your carry-on to avoid delays and stressful administrative hurdles after arrival.